Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL)

    Price:

    25.35 USD

    ( - -0.08 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    HROWL
    Name
    Harrow Health, Inc. 8.625% Senior Notes due 2026
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    Price
    25.350
    Market Cap
    1.353B
    Enterprise value
    1.378B
    Currency
    USD
    Ceo
    Mark L. Baum
    Full Time Employees
    217
    Ipo Date
    2021-05-07
    City
    Nashville
    Address

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    High Tide Inc.

    VALUE SCORE:

    8

    Symbol
    HITI
    Market Cap
    399.986M
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    2nd position

    Insmed Incorporated

    VALUE SCORE:

    8

    Symbol
    INSM
    Market Cap
    27.876B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare

    The best

    BeOne Medicines Ltd.

    VALUE SCORE:

    9

    Symbol
    ONC
    Market Cap
    33.518B
    Industry
    Medical - Pharmaceuticals
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -140.715
    P/S
    6.358
    P/B
    28.985
    Debt/Equity
    4.657
    EV/FCF
    -47.287
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    7.141
    Earnings yield
    -0.007
    Debt/assets
    0.670
    FUNDAMENTALS
    Net debt/ebidta
    5.554
    Interest coverage
    0.579
    Research And Developement To Revenue
    0.057
    Intangile to total assets
    0.517
    Capex to operating cash flow
    9.517
    Capex to revenue
    0.169
    Capex to depreciation
    2.187
    Return on tangible assets
    -0.061
    Debt to market cap
    0.160
    Piotroski Score
    3.000
    FUNDAMENTALS
    PEG
    -2.682
    P/CF
    356.511
    P/FCF
    -42.101
    RoA %
    -2.964
    RoIC %
    4.895
    Gross Profit Margin %
    74.564
    Quick Ratio
    0.576
    Current Ratio
    0.622
    Net Profit Margin %
    -4.493
    Net-Net
    -4.830
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.935
    Revenue per share
    6.188
    Net income per share
    -0.278
    Operating cash flow per share
    0.110
    Free cash flow per share
    -0.935
    Cash per share
    1.440
    Book value per share
    1.340
    Tangible book value per share
    -3.511
    Shareholders equity per share
    1.350
    Interest debt per share
    6.961
    TECHNICAL
    52 weeks high
    25.730
    52 weeks low
    25.000
    Current trading session High
    25.390
    Current trading session Low
    25.280
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    3.000
    Years of div.
    5.000
    Q-shift
    1.000
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Technology
    Industry
    Consumer Electronics
    Dividend yield
    0%
    Payout Ratio
    -9.9794485%
    P/E
    -1.140
    logo

    Country
    US
    Sector
    Technology
    Industry
    Consumer Electronics
    Dividend yield
    0%
    Payout Ratio
    -9.9794485%
    P/E
    -1.140
    logo

    Country
    US
    Sector
    Financial Services
    Industry
    Financial - Conglomerates
    Dividend yield
    0%
    Payout Ratio
    -5.1908087%
    P/E
    -0.220
    logo

    Country
    BM
    Sector
    Financial Services
    Industry
    Insurance - Reinsurance
    Dividend yield
    0%
    Payout Ratio
    9.428403000000001%
    P/E
    17.783
    DESCRIPTION

    Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

    NEWS